Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 8 of about 8 for Christopher L. White
Company Exchange Symbol Last price Quote change Market cap
Align Technology, Inc. NASDAQ ALGN 58.78 -0.01 (-0.02%) 4.67B
Align Technology, Inc. (Align) is a medical device company. The Company designs, manufactures and markets a system of clear aligner therapy, ...
Executive:
Christopher C. Puco
Pra Group Inc NASDAQ PRAA 26.21 +0.37 (1.43%) 1.28B
PRA Group Inc. (PRA Group) formerly Portfolio Recovery Associates Inc. and its subsidiaries is a financial and business service company.
Executive:
Christopher B. Graves
Old National Bancorp NASDAQ ONB 11.09 +0.24 (2.21%) 1.30B
Old National Bancorp (Old National) is a financial holding company. The Company through its wholly owned banking subsidiary provides a range of services, ...
Executive:
Christopher A. Wolking
Rent-A-Center Inc NASDAQ RCII 11.45 +0.53 (4.85%) 637.12M
Rent-A-Center, Inc. is a rent-to-own operator in North America. The Company provides an opportunity to obtain ownership of products, such as consumer ...
Executive:
Christopher A. Korst
CLARCOR Inc. NYSE CLC 46.29 +1.19 (2.64%) 2.32B
CLARCOR Inc. is engaged in the marketing and manufacturing of mobile, industrial and environmental filtration products. The Company's segments are ...
Executive:
Christopher L. Conway
Era Group Inc NYSE ERA 7.65 +0.13 (1.73%) 159.52M
Era Group Inc. is engaged in operating helicopters. The Company's helicopters transport personnel to, from and between offshore installations, drilling rigs ...
Executive:
Christopher Bradshaw
UNITE Group plc LON UTG 608.50 -2.50 (-0.41%) 1.33B
The UNITE Group Plc is a developer and operator of student accommodation. The Company's properties provide accommodation close to University campuses, ...
Executive:
Christopher Szpojnarowicz
Oxford Pharmascience Group Plc LON OXP 4.80 -0.20 (-4.00%) 59.29M
Oxford Pharmascience Group plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in re-developing medicines.
Executive:
Christopher Hill